BCM
FLACW

Bluefin Capital Management’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Bluefin Capital Management’s Portfolio FLACW Stock Details FLACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-21,322
Closed -$2K – 490
2022
Q2 		$2K Sell
21,322
-1,007
-5% -$94 ﹤0.01% 301
2022
Q1 		$4K Buy
22,329
+221
+1% +$40 ﹤0.01% 335
2021
Q4 		$13K Buy
+22,108
New +$13K ﹤0.01% 544